ALK and neuroblastoma: Indeed, miR-1304-5p inhibition enhanced cell viability, in multiple genetically distinct NB cell lines regardless of ALK or other genetic status; miR-1304-5p upregulation had the opposite effect, suggesting this as a potential therapeutic vulnerability across multiple genetic sub-types of NB.